// App-Quantinova.ai

1084 : CD44 Antibody Mediated Amelioration of Murine ITP: Evidence for a Similar Strain Dependent Fc?RIIB Requirement As Compared to Ivig

Researchers

Presenter

  • Alan H Lazarus

Principal Investigators

  • N/A

Medical Centers

  • Canadian Blood Services, Toronto, ON, Canada

  • Research and Development, Canadian Blood Services, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Thrombocytopenia

Biomarkers

  • Cluster of Differentiation 44

  • Immunoglobulin G

Drug/Treatment

  • IVIG

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved